29 Mar
Dose-Conversion Ratio for Epoetin Alfa: DISCUSSION
This secondary analysis of patients is from the first randomized head-to-head clinical trial that was designed and powered to evaluate the efficacy of EPO 40,000 units once weekly versus DARB 200 mcg every two weeks. The DCR point estimate was 199:1 in the base case scenario, with a tight range of 190:1 to 207:1, depending [...]